Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS)

CNY 31.24

(-1.26%)

Operating Expenses Summary of Guangzhou Kingmed Diagnostics Group Co., Ltd.

Guangzhou Kingmed Diagnostics Group Co., Ltd.'s latest annual operating expenses in 2023 was 2.35 Billion CNY , down -18.47% from previous year.
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s latest quarterly operating expenses in 2024 Q3 was 621.63 Million CNY , up 3.56% from previous quarter.
Guangzhou Kingmed Diagnostics Group Co., Ltd. reported a annual operating expenses of 3.07 Billion CNY in annual operating expenses 2022, up 10.96% from previous year.
Guangzhou Kingmed Diagnostics Group Co., Ltd. reported a annual operating expenses of 2.77 Billion CNY in annual operating expenses 2021, up 42.18% from previous year.
Guangzhou Kingmed Diagnostics Group Co., Ltd. reported a quarterly operating expenses of 624.6 Million CNY for 2024 Q1, down -0.59% from previous quarter.
Guangzhou Kingmed Diagnostics Group Co., Ltd. reported a quarterly operating expenses of 621.63 Million CNY for 2024 Q3, up 3.56% from previous quarter.

Annual Operating Expenses Chart of Guangzhou Kingmed Diagnostics Group Co., Ltd. (2023 - 2012)

Historical Annual Operating Expenses of Guangzhou Kingmed Diagnostics Group Co., Ltd. (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	2.35 Billion CNY	-18.47%
2022	3.07 Billion CNY	10.96%
2021	2.77 Billion CNY	42.18%
2020	1.95 Billion CNY	23.24%
2019	1.58 Billion CNY	13.26%
2018	1.39 Billion CNY	11.96%
2017	1.24 Billion CNY	9.79%
2016	1.13 Billion CNY	26.13%
2015	901.36 Million CNY	16.83%
2014	771.53 Million CNY	51.8%
2013	508.26 Million CNY	60.54%
2012	316.6 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	596.98 Million CNY	-4.42%
2024 Q1	624.6 Million CNY	-0.59%
2024 Q3	621.63 Million CNY	3.56%
2023 Q3	580.24 Million CNY	10.46%
2023 Q4	628.34 Million CNY	8.29%
2023 FY	2.5 Billion CNY	-18.47%
2023 Q1	486.58 Million CNY	-37.7%
2023 Q2	525.28 Million CNY	7.95%
2022 Q3	744.92 Million CNY	3.99%
2022 Q2	716.33 Million CNY	-14.2%
2022 Q1	834.85 Million CNY	-3.7%
2022 FY	3.07 Billion CNY	10.96%
2022 Q4	781.02 Million CNY	4.85%
2021 Q2	628.24 Million CNY	6.01%
2021 FY	2.77 Billion CNY	42.18%
2021 Q4	866.96 Million CNY	26.48%
2021 Q1	592.64 Million CNY	-4.5%
2021 Q3	685.44 Million CNY	9.1%
2020 Q1	342.5 Million CNY	-17.33%
2020 Q2	482.41 Million CNY	40.85%
2020 FY	1.95 Billion CNY	23.24%
2020 Q4	620.55 Million CNY	22.86%
2020 Q3	505.07 Million CNY	4.7%
2019 Q1	367.04 Million CNY	0.29%
2019 FY	1.58 Billion CNY	13.26%
2019 Q4	414.32 Million CNY	1.87%
2019 Q3	406.72 Million CNY	3.06%
2019 Q2	394.64 Million CNY	7.52%
2018 Q4	365.97 Million CNY	0.39%
2018 FY	1.39 Billion CNY	11.96%
2018 Q3	364.53 Million CNY	3.98%
2018 Q2	350.59 Million CNY	10.81%
2018 Q1	316.38 Million CNY	3.39%
2017 Q1	295.2 Million CNY	-5.19%
2017 Q3	328.04 Million CNY	2.84%
2017 Q4	306.01 Million CNY	-6.72%
2017 Q2	318.97 Million CNY	8.05%
2017 FY	1.24 Billion CNY	9.79%
2016 Q4	311.35 Million CNY	7.46%
2016 Q3	289.73 Million CNY	0.0%
2016 FY	1.13 Billion CNY	26.13%
2015 Q4	272.31 Million CNY	0.0%
2015 FY	901.36 Million CNY	16.83%
2014 FY	771.53 Million CNY	51.8%
2013 FY	508.26 Million CNY	60.54%
2012 FY	316.6 Million CNY	0.0%

Peer Operating Expenses Comparison of Guangzhou Kingmed Diagnostics Group Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Shanghai Runda Medical Technology Co., Ltd.	1.78 Billion CNY	-31.964%
Joinn Laboratories(China)Co.,Ltd.	505.68 Million CNY	-365.766%
WuXi AppTec Co., Ltd.	4.73 Billion CNY	50.307%
Autobio Diagnostics Co., Ltd.	1.52 Billion CNY	-54.381%
Thalys Medical Technology Group Inc.	570.05 Million CNY	-313.174%
Chemclin Diagnostics Co., Ltd.	169.33 Million CNY	-1290.96%